These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 451498)

  • 1. [The biological effect of purely synthetic human insulin in patients with diabetes mellitus].
    Teuscher A
    Schweiz Med Wochenschr; 1979 May; 109(20):743-7. PubMed ID: 451498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of transfer from animal-source insulins to biosynthetic human insulin (rDNA E coli) in patients with diabetes mellitus.
    Garber AJ; Davidson JA; Krosnick A; Beaser RS; Anderson JH
    Clin Ther; 1991; 13(5):627-36. PubMed ID: 1799920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health behaviour and its determinants among insulin-dependent diabetics. Results of the diabetes Warsaw study.
    Wysocki M; Czyzyk A; Slonska Z; Krolewski A; Janeczko D
    Diabete Metab; 1978 Jun; 4(2):117-22. PubMed ID: 680311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexible intensive insulin therapy in adults with type 1 diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis.
    Sämann A; Mühlhauser I; Bender R; Hunger-Dathe W; Kloos C; Müller UA
    Diabetes Care; 2006 Oct; 29(10):2196-9. PubMed ID: 17003292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.
    Holstein A; Hammer C; Plaschke A; Ptak M; Kuhn J; Diekmann J; Kleesiek K; Egberts EH
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):429-34. PubMed ID: 15372362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with chlorpropamide-phenformin combination in adult, obese, ketosis-resistant diabetics.
    Lev-Ran AS
    Isr J Med Sci; 1971 Jun; 7(6):727-32. PubMed ID: 4997820
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical observation on brittle diabetes.
    Lev-Ran A
    Arch Intern Med; 1978 Mar; 138(3):372-6. PubMed ID: 629631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe hypoglycemia in diabetics with impaired renal function].
    Hasslacher C; Wittmann W
    Dtsch Med Wochenschr; 2003 Feb; 128(6):253-6. PubMed ID: 12571792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of highly purified semi-synthetic insulin and highly purified porcine insulin in the treatment of type I diabetes: interim report of a multi-centre randomised single blind study.
    Birtwell AJ; Owens DR; Jones IR; Hayes TM; Beale DJ; el-Shaboury AH; Arora P; Reeves WG
    Diabete Metab; 1984 Dec; 10(5):295-8. PubMed ID: 6397365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lasting improvement in the adjustment of insulin-dependent type I and type II diabetics with blood sugar and urinary sugar control by the patient].
    Knick B; Groth U; Koberstein R; Panitz N
    Med Welt; 1983 Jan; 34(1):15-8. PubMed ID: 6338339
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are there problems in changing diabetic patients from animal to human insulin?].
    Fankhauser S; von Rohr E
    Ther Umsch; 1990 Jan; 47(1):41-8. PubMed ID: 2408181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin glargine (Lantus).
    Owens DR; Griffiths S
    Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin and energy restriction on the thermic effect of protein in type 2 diabetes mellitus.
    Gougeon R
    Obes Res; 2001 Apr; 9(4):241-50. PubMed ID: 11331427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nocturnal hypoglycemia with reference to hormonal counterregulation in type I diabetics receiving insulin therapy].
    Caduff F; Vonesch HJ; Klopfstein M; Berger W
    Schweiz Med Wochenschr; 1989 Jan; 119(1):9-15. PubMed ID: 2644692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leo-insulins in the treatment of diabetes. Experiences from an internal medicine practice].
    Roth U
    Fortschr Med; 1980 Jul; 98(25):995-8. PubMed ID: 7005038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ Growth hormone in patients with diabetes mellitus of the juvenile type].
    Navarro Rizo JL; Espinosa De Los Monteros Mena A; Chvarría Bonequi C
    Bol Med Hosp Infant Mex; 1978; 35(6):1093-107. PubMed ID: 687419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic agents.
    Francisco GE
    Prim Care; 1990 Sep; 17(3):499-519. PubMed ID: 2236334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.